Reduced water intake and body weight were observed in 4 months old tg-ArcSwe animals.
In this study an increase in skeletal muscle mass and body weight were observed without altering heart weight.
Apart from the higher BMD of ctsk−/− animals, no significant differences in body weight were observed for mice with ctsk deficiency compared to WT animals (data not shown).
No significant differences in body weight were observed in mice in connection to genotype or treatment, (e.g. P. g, FSL-1).
No differences in body weight were observed between p55+/+LDLR−/− and p55−/−LDLR−/− mice infused with AngII, while plasma cholesterol levels were approximately 25% reduced at the end of the study in p55−/−LDLR−/− mice (Fig. 5A, B, C).
No signs of disease or major changes in body weight were observed in any of the mice after infection with 105 EID50 or 107 EID50 of any of the three viruses (data not shown).
At 8-week-old age, at which no significant differences in body weight were observed between neonatal SAL- and DEX-treated rats, DEX-treated rats exhibited normal hippocampal synaptic plasticity and contextual fear memory performance compared with SAL-treated rats [9].
No significant differences in mean body weight were observed for either males or females from the Myo-CELFΔ-370 line when compared to sex-matched wild type littermates over a sixteen-week time course, suggesting that there are no gross changes in overall muscle mass or body morph (Figure S1).
At birth, the offspring born to dams fed the low protein diet weighed significantly less than their control counterparts (5.97±0.09 g vs 7.00±0.18; P<0.0001) but they showed later a delayed catch-up growth such that at the completion of the study no statistically significant differences in body weight were observed between the two groups (Table 1).
No changes in body weight were observed.
Decreases in body weight were observed in all groups.
